Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metastatic breast cancer

R D Rubens1

  • 11CRF Clinical Oncology Unit, Guy's Hospital, London, UK.

Current Opinion in Oncology
|November 1, 1993
PubMed
Summary

New antiestrogens and targeted therapies are emerging for metastatic breast cancer, challenging tamoxifen. Research is ongoing into chemotherapy optimization, immunotherapy, and bisphosphonates for managing bone metastases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The interaction of oestrogen receptor status and pathological features with adjuvant treatment in relation to survival in patients with operable breast cancer: a retrospective study of 2660 patients.

Endocrine-related cancer·2004
Same author

Epirubicin in patients with liver dysfunction: development and evaluation of a novel dose modification scheme.

European journal of cancer (Oxford, England : 1990)·2003
Same author

7. Management of advanced breast cancer.

International journal of clinical practice·2002
Same author

Metastatic eccrine porocarcinoma: response to docetaxel (Taxotere) chemotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2001
Same author

Risk of complications from bone metastases in breast cancer. implications for management.

European journal of cancer (Oxford, England : 1990)·2000
Same author

The biology and management of bone metastases.

Critical reviews in oncology/hematology·1999

Area of Science:

  • Oncology
  • Pharmacology
  • Immunology

Background:

  • Tamoxifen's role in metastatic breast cancer treatment is evolving.
  • Emerging therapies include less estrogenic antiestrogens, aromatase inhibitors, and estrone sulfatase inhibitors.
  • Novel cytotoxic agents like anthrapyrazoles show promise with high efficacy and low toxicity.

Purpose of the Study:

  • To review recent advancements in the treatment of metastatic breast cancer.
  • To discuss the challenges and ongoing research in chemotherapy, immunotherapy, and bone metastasis management.

Main Methods:

  • Literature review of recent developments in breast cancer therapeutics.
  • Analysis of emerging treatment modalities including hormonal therapy, chemotherapy intensification, immunotherapy, and bisphosphonates.

Main Results:

  • New antiestrogens and enzyme inhibitors offer alternatives to tamoxifen.
  • Anthrapyrazoles demonstrate potent cytotoxic activity with reduced toxicity.
  • Chemotherapy intensification with bone marrow support is under investigation but not yet routine for palliative care.
  • Active specific immunotherapy is feasible with identified tumor antigens.
  • Bisphosphonates show consistent evidence in reducing bone metastasis morbidity.

Conclusions:

  • The treatment landscape for metastatic breast cancer is expanding with novel agents and strategies.
  • Further research is needed to establish optimal chemotherapy durations and the role of intensified regimens.
  • Immunotherapy and bisphosphonates represent promising avenues for improving patient outcomes and managing skeletal-related events.

Related Experiment Videos